167 related articles for article (PubMed ID: 17912490)
1. Increased serum levels of soluble CD30 in patients with common variable immunodeficiency and its clinical implications.
Rezaei N; Haji-Molla-Hoseini M; Aghamohammadi A; Pourfathollah AA; Moghtadaie M; Pourpak Z
J Clin Immunol; 2008 Jan; 28(1):78-84. PubMed ID: 17912490
[TBL] [Abstract][Full Text] [Related]
2. Soluble CD26 and CD30 levels in patients with common variable immunodeficiency.
Mahmoudi M; Hedayat M; Aghamohammadi A; Rezaei N
J Investig Allergol Clin Immunol; 2013; 23(2):120-4. PubMed ID: 23654079
[TBL] [Abstract][Full Text] [Related]
3. Serum bactericidal antibody responses to meningococcal polysaccharide vaccination as a basis for clinical classification of common variable immunodeficiency.
Rezaei N; Aghamohammadi A; Siadat SD; Moin M; Pourpak Z; Nejati M; Ahmadi H; Kamali S; Norouzian D; Tabaraei B; Read RC
Clin Vaccine Immunol; 2008 Apr; 15(4):607-11. PubMed ID: 18235041
[TBL] [Abstract][Full Text] [Related]
4. Elevated levels of activated CD4 T cells in common variable immunodeficiency: association with clinical findings.
Carbone J; Sarmiento E; Micheloud D; Rodríguez-Molina J; Fernández-Cruz E
Allergol Immunopathol (Madr); 2006; 34(4):131-5. PubMed ID: 16854344
[TBL] [Abstract][Full Text] [Related]
5. Lymphocyte Subset Abnormalities in Pediatric-Onset Common Variable Immunodeficiency.
Ogulur I; Kiykim A; Baser D; Karakoc-Aydiner E; Ozen A; Baris S
Int Arch Allergy Immunol; 2020; 181(3):228-237. PubMed ID: 31901904
[TBL] [Abstract][Full Text] [Related]
6. Comparison of various classifications for patients with common variable immunodeficiency (CVID) using measurement of B-cell subsets.
Yazdani R; Seify R; Ganjalikhani-Hakemi M; Abolhassani H; Eskandari N; Golsaz-Shirazi F; Ansaripour B; Salehi E; Azizi G; Rezaei N; Aghamohammadi A
Allergol Immunopathol (Madr); 2017; 45(2):183-192. PubMed ID: 27717724
[TBL] [Abstract][Full Text] [Related]
7. Response to polysaccharide vaccination amongst pediatric patients with common variable immunodeficiency correlates with clinical disease.
Rezaei N; Aghamohammadi A; Read RC
Iran J Allergy Asthma Immunol; 2008 Dec; 7(4):231-4. PubMed ID: 19052353
[TBL] [Abstract][Full Text] [Related]
8. Immunophenotypic profile of T cells in common variable immunodeficiency: is there an association with different clinical findings?
Lanio N; Sarmiento E; Gallego A; Carbone J
Allergol Immunopathol (Madr); 2009; 37(1):14-20. PubMed ID: 19268056
[TBL] [Abstract][Full Text] [Related]
9. CD4+CD25+Foxp3+ T regulatory cells, Th1 (CCR5, IL-2, IFN-γ) and Th2 (CCR4, IL-4, Il-13) type chemokine receptors and intracellular cytokines in children with common variable immunodeficiency.
Kutukculer N; Azarsiz E; Aksu G; Karaca NE
Int J Immunopathol Pharmacol; 2016 Jun; 29(2):241-51. PubMed ID: 26684629
[TBL] [Abstract][Full Text] [Related]
10. Impaired secretion of IL-10 by T cells from patients with common variable immunodeficiency--involvement of protein kinase A type I.
Holm AM; Aukrust P; Aandahl EM; Müller F; Taskén K; Frøland SS
J Immunol; 2003 Jun; 170(11):5772-7. PubMed ID: 12759461
[TBL] [Abstract][Full Text] [Related]
11. Analysis of class-switched memory B cells in patients with common variable immunodeficiency and its clinical implications.
Vodjgani M; Aghamohammadi A; Samadi M; Moin M; Hadjati J; Mirahmadian M; Parvaneh N; Salavati A; Abdollahzade S; Rezaei N; Srrafnejad A
J Investig Allergol Clin Immunol; 2007; 17(5):321-8. PubMed ID: 17982925
[TBL] [Abstract][Full Text] [Related]
12. Utility of peripheral blood B cell subsets analysis in common variable immunodeficiency.
Al Kindi M; Mundy J; Sullivan T; Smith W; Kette F; Smith A; Heddle R; Hissaria P
Clin Exp Immunol; 2012 Feb; 167(2):275-81. PubMed ID: 22236004
[TBL] [Abstract][Full Text] [Related]
13. [Common variable immunodeficiency: Clinical and immunological characterization of patients and homogeneous subgroup definition by means of B lymphocyte subpopulation typing].
Vélez AC; Castaño DM; Gómez RD; Orrego JC; Moncada M; Franco JL
Biomedica; 2015; 35(1):101-16. PubMed ID: 26148039
[TBL] [Abstract][Full Text] [Related]
14. Chronic immune activation in common variable immunodeficiency (CVID) is associated with elevated serum levels of soluble CD14 and CD25 but not endotoxaemia.
Litzman J; Nechvatalova J; Xu J; Ticha O; Vlkova M; Hel Z
Clin Exp Immunol; 2012 Dec; 170(3):321-32. PubMed ID: 23121673
[TBL] [Abstract][Full Text] [Related]
15. Expansion of CD19(hi)CD21(lo/neg) B cells in common variable immunodeficiency (CVID) patients with autoimmune cytopenia.
Warnatz K; Wehr C; Dräger R; Schmidt S; Eibel H; Schlesier M; Peter HH
Immunobiology; 2002 Dec; 206(5):502-13. PubMed ID: 12607725
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic Analysis of CD4+ Treg, CD8+ Treg, and Breg Cells in Adult Common Variable Immunodeficiency Patients.
Yesillik S; Agrawal S; Gollapudi SV; Gupta S
Int Arch Allergy Immunol; 2019; 180(2):150-158. PubMed ID: 31284281
[TBL] [Abstract][Full Text] [Related]
17. Circulating Helper T-Cell Subsets and Regulatory T Cells in Patients With Common Variable Immunodeficiency Without Known Monogenic Disease.
Azizi G; Mirshafiey A; Abolhassani H; Yazdani R; Jafarnezhad-Ansariha F; Shaghaghi M; Mortazavi-Jahromi SS; Noorbakhsh F; Rezaei N; Aghamohammadi A
J Investig Allergol Clin Immunol; 2018; 28(3):172-181. PubMed ID: 29345621
[TBL] [Abstract][Full Text] [Related]
18. Plasma levels of soluble CD30 are increased in children with chronic renal failure and with primary growth deficiency and decrease during treatment with recombination human growth hormone.
Barbano G; Cappa F; Prigione I; Pistoia V; Cohen A; Chiesa S; Gusmano R; Perfumo F
Nephrol Dial Transplant; 2001 Sep; 16(9):1807-13. PubMed ID: 11522862
[TBL] [Abstract][Full Text] [Related]
19. The Significance of B-cell Subsets in Patients with Unclassified Hypogammaglobulinemia and Association with Intravenous Immunoglobulin Replacement Requirement.
Karaman S; Erdem SB; Gülez N; Genel F
Iran J Immunol; 2018 Mar; 15(1):1-13. PubMed ID: 29549228
[TBL] [Abstract][Full Text] [Related]
20. Serum level of the soluble form of the CD30 molecule identifies patients with Hodgkin's disease at high risk of unfavorable outcome.
Nadali G; Tavecchia L; Zanolin E; Bonfante V; Viviani S; Camerini E; Musto P; Di Renzo N; Carotenuto M; Chilosi M; Krampera M; Pizzolo G
Blood; 1998 Apr; 91(8):3011-6. PubMed ID: 9531614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
